Pfizer looks to sell Midtown East HQ by the end of 2017

1M sf property on East 42nd Street is sticky subject in area’s rezoning

TRD New York /
Oct.October 07, 2016 09:03 AM

Global pharmaceutical giant Pfizer is looking to sell its headquarters in Manhattan, a property that is becoming a contentious sticking point in the proposal to rezone Midtown East.

Pfizer told employees it plans to sell its aging buildings at 219 East 42nd Street and 235 East 42nd Street by the end of next year, the Wall Street Journal reported, and expects to lease a new headquarters somewhere in Manhattan.

The buildings are interconnected and have about 1 million square feet of space between them. It had previously mulled a redevelopment of the headquarters. The company thinks it would move no earlier than the first half of 2019.

“In order to bring our building up to modern standards, it is going to take a significant investment,” a Pfizer spokesperson said. “In terms of capital deployment, that is not where we want to focus.”

Company executives said that a “substantial majority” of those employees working in the current headquarters will stay in Manhattan, though some may be relocated to other locations throughout the tri-state area.

Pfizer expected to relocate its tax residence to Ireland earlier this year as part of its acquisition of the Dublin-based company Allergan, but that move was effectively quashed after the Obama administration made changes to tax laws.

The Pfizer property has a denser zoning than nearby parcels in Midtown East, and community advocates want to see the owner – whoever it may be – make more contributions to public improvements if the site is rezoned as part of the broader effort to modernize the business district. [WSJ]Rich Bockmann

 

Related Articles

arrow_forward_ios
Photo illustration of GDSNY CEO Michael Kirchmann, Klövern CEO Rutger Arnhult and 417 Park Avenue (Google Maps, iStock)

Klövern, GDS finance 417 Park Ave with $100M in Swedish bonds

Klövern, GDS finance 417 Park Ave with $100M in Swedish bonds
From left: GDSNY CEO Michael Kirchmann, 417 Park Avenue and Klövern CEO Rutger Arnhult (Credit: Google Maps)

GDS Development, Klövern buy Midtown East co-op for $184M

GDS Development, Klövern buy Midtown East co-op for $184M
575 Lexington Avenue (Credit: Google Maps, iStock)

Normandy looks to sell 575 Lex for more than $650M

Normandy looks to sell 575 Lex for more than $650M
Clockwise from left: 270 Park Avenue, 1-15 57th Avenue and 57-28 Second Street in Queens and 310 Hudson Street (credit: Wikipedia, Handel Architects, Google Maps)

Behold the largest projects of 2019

Behold the largest projects of 2019
305 East 46th Street (Credit: iStock)

Japanese firm lands $84M financing for Midtown East buy

Japanese firm lands $84M financing for Midtown East buy
219 East 44th Street (Credit: StreetEasy and iStock)

This seven-story $53M penthouse has been broken up into six units. The first just hit the market for $16M.

This seven-story $53M penthouse has been broken up into six units. The first just hit the market for $16M.
Clockwise from top left: 237-24` East 62nd Street, 957 Woodycrest Avenue, 210 Clarkson Avenue, 950 Woodycrest Avenue (Credit: Google Maps)

Here’s what the $10M-$30M NYC investment sales market looked like last week

Here’s what the $10M-$30M NYC investment sales market looked like last week
Asset manager Davidson Kempner to upgrade Westin Grand Central hotel

Asset manager Davidson Kempner to upgrade Westin Grand Central hotel

Asset manager Davidson Kempner to upgrade Westin Grand Central hotel
arrow_forward_ios

The Deal's newsletters give you the latest scoops, fresh headlines, marketing data, and things to know within the industry.

Loading...